An overview of process development for antibody-drug conjugates produced by chemical conjugation technology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of process development for antibody-drug conjugates produced by chemical conjugation technology

Published:2020-12-01 Issue:7 Volume:21 Page:963-975
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Matsuda Yutaka¹^ORCID,Mendelsohn Brian A.²^ORCID

Affiliation:

1. Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki 210-8681, Japan

2. Process Development & Tech Transfer, Ajinomoto Bio-Pharma Services, 11040 Roselle Street, San Diego, CA 92121, United States.

Funder

Ajinomoto Co., Inc

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1846714

Reference130 articles.

1. Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes

2. Antibody–Drug Conjugates: A Comprehensive Review

3. Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy

4. Antibody-drug conjugates as targeted therapies: Are we there yet? A critical review of the current clinical landscape

5. Antibody–Drug Conjugates: The Last Decade

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaged capillary isoelectric focusing method development for charge variants of high DAR ADCs;Analytica Chimica Acta;2024-11

2. Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers;International Journal of Biological Macromolecules;2024-10

3. Evaluation of High-Affinity Monoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved FRET;ACS Medicinal Chemistry Letters;2024-08-30

4. Evaluation of High-Affinity Monoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved FRET;2024-08-06

5. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3